CI vs TOVX · P/E 2.4, rev $140.16B vs rev $300.0K
Cigna Corp (CI) versus Theriva Biologics Inc. (TOVX) — a side-by-side from cached financials, not a winner call.
Cigna Corp (CI) is a healthcare plans company listed on US.
Theriva Biologics Inc. (TOVX) is a biotechnology company listed on NYSE MKT.
Latest reported CI revenue for 2026-06-30 was $140.16B. Net income was $3.31B. CI currently screens at market cap $71.62B and trailing P/E 2.4.
Latest reported TOVX revenue for 2026-06-30 was $300.0K. Net income was -$5.3M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. TOVX currently screens at market cap $12.4M.
CI currently screens at market cap $71.62B and trailing P/E 2.4. TOVX currently screens at market cap $12.4M.
Not investment advice. Open the CI and TOVX stock pages for the full models.
Not investment advice.